Literature DB >> 8066047

Current topic: confined placental mosaicism and intrauterine fetal development.

D K Kalousek1.   

Abstract

Chromosomal mosaicism is the presence of two or more cell lines with different chromosomal complements in an individual derived from a single zygote (which is distinguishable from chimaerism in which an individual is derived from more than one zygote). Mosaicism may involve a number of different karyotypic abnormalities including those for whole sets of chromosomes (polyploidy, including triploidy and tetraploidy), trisomies, sex chromosomal anomalies and chromosomal rearrangements. Mosaicism itself may be present in all the tissues of the body and placenta, or it may only be seen in certain tissues or may be restricted to only the placenta and extraembryonic membranes. The type of mosaicism seen depends upon the stage of development at which it originated, the tissue types to which the abnormal cell lines were distributed and the cell cycle times of both the normal and abnormal cells. The phenotypic effects or consequences of chromosomal mosaicism may be dramatic. During the pregnancy, high levels of mosaicism are seen in early abnormal preimplantation embryos, spontaneous abortions, intrauterine growth restriction and intrauterine fetal death. However, not all cases of mosaicism are serious and the presence of a normal cell line may dilute the effects of an abnormal cell line to such an extent that in many cases mosaicism will remain undetected because the consequences are not severe. Investigations of chromosomal mosaicism were, until recently, restricted to those cells which could be induced to divide and be karyotyped from metaphase analysis. Advances in molecular genetics and cytogenetics have made possible the identification of chromosomal abnormalities, specifically mosaicism in interphase cells. The identification of abnormalities such as confined placental mosaicism and its association with uniparental disomy has led to the recognition that chromosomal mosaicism plays a major role in abnormal human development and dysmorphology (Hall, 1990). An understanding of mosaicism and the role of the placenta during development, including the phenomenon of trisomic zygote rescue, is helping to cast light on problems in prenatal diagnosis, many of which involve confined placental mosaicism.

Entities:  

Mesh:

Year:  1994        PMID: 8066047     DOI: 10.1016/0143-4004(94)90014-0

Source DB:  PubMed          Journal:  Placenta        ISSN: 0143-4004            Impact factor:   3.481


  7 in total

Review 1.  The control of mammalian female meiosis: factors that influence chromosome segregation.

Authors:  P A Hunt
Journal:  J Assist Reprod Genet       Date:  1998-05       Impact factor: 3.412

2.  A partial hydatidiform mole with 2N/3N mosaicism identified by molecular analysis.

Authors:  Y Ikeda; Y Jinno; H Masuzaki; N Niikawa; T Ishimaru
Journal:  J Assist Reprod Genet       Date:  1996-10       Impact factor: 3.412

3.  An analysis of common isodisomic regions in five mUPD 16 probands.

Authors:  S N Abu-Amero; Z Ali; K K Abu-Amero; P Stanier; G E Moore
Journal:  J Med Genet       Date:  1999-03       Impact factor: 6.318

4.  Lack of checkpoint control at the metaphase/anaphase transition: a mechanism of meiotic nondisjunction in mammalian females.

Authors:  R LeMaire-Adkins; K Radke; P A Hunt
Journal:  J Cell Biol       Date:  1997-12-29       Impact factor: 10.539

5.  Evaluation of triploid<-->diploid and trisomy-3<-->diploid mouse chimeras as models for investigating how lineage restriction occurs in confined placental mosaicism.

Authors:  Clare A Everett; Margaret A Keighren; Jean H Flockhart; John D West
Journal:  Reproduction       Date:  2007-12       Impact factor: 3.906

Review 6.  Chromosomal Mosaicism in Human Feto-Placental Development: Implications for Prenatal Diagnosis.

Authors:  Francesca Romana Grati
Journal:  J Clin Med       Date:  2014-07-24       Impact factor: 4.241

7.  Unexpected finding of uniparental disomy mosaicism in term placentas: Is it a common feature in trisomic placentas?

Authors:  Diane Van Opstal; Karin E M Diderich; Marieke Joosten; Lutgarde C P Govaerts; Joke Polak; Marjan Boter; Jasper J Saris; Wai Yee Cheung; Stefanie van Veen; Robert van de Helm; Attie T J I Go; Maarten F C M Knapen; Dimitri N M Papatsonis; Anneke Dijkman; Femke de Vries; Robert-Jan H Galjaard; Lies H Hoefsloot; Malgorzata I Srebniak
Journal:  Prenat Diagn       Date:  2018-09-27       Impact factor: 3.050

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.